Skip to main content

August 2013, Vol 6 ADA 2013 Highlights

GLP-1 Agonists May Protect Patients with Diabetes from Heart Failure

Highlights from the ADA President’s Research Sessions

Look AHEAD: Lifestyle Intervention Cost-Effective in Overweight Patients with Type 2 Diabetes

SGLT-2 Inhibitors Show Durability in Glycemic Control, Weight-Loss Maintenance

Pooled Analysis Confirms CV Benefits of DPP-4 Inhibition

Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes

Novel Predictors of Outcomes in Diabetes

Reductions in HbA1c Levels, Hypoglycemia, and Weight with Linagliptin in Patients with Type 2 Diabetes and Renal Impairment

Lifestyle Intervention Beneficial in Patients with Diabetes, but Not for CV Parameters

Page 2 of 2
Results 11 - 19 of 19